mabron retard toimeainet prolongeeritult vabastav tablett
medochemie ltd - tramadool - toimeainet prolongeeritult vabastav tablett - 100mg 50tk; 100mg 100tk; 100mg 90tk; 100mg 30tk; 100mg 180tk; 100mg 120tk; 100mg 20tk; 100mg 10tk; 100mg 60tk; 100mg 500tk
lidiaq kreem
qp-services uk ltd - lidokaiin - kreem - 40mg 1g 5g 1tk; 40mg 1g 5g 5tk
mabron retard toimeainet prolongeeritult vabastav tablett
medochemie ltd - tramadool - toimeainet prolongeeritult vabastav tablett - 150mg 30tk; 150mg 180tk; 150mg 60tk; 150mg 100tk; 150mg 120tk; 150mg 50tk; 150mg 90tk; 150mg 500tk; 150mg 10tk; 150mg 20tk
zantac õhukese polümeerikattega tablett
glaxosmithkline export ltd - ranitidiin - õhukese polümeerikattega tablett - 150mg 60tk; 150mg 20tk
zantac 75 õhukese polümeerikattega tablett
glaxosmithkline export ltd - ranitidiin - õhukese polümeerikattega tablett - 75mg 24tk; 75mg 12tk
mabron retard toimeainet prolongeeritult vabastav tablett
medochemie ltd - tramadool - toimeainet prolongeeritult vabastav tablett - 200mg 50tk; 200mg 180tk; 200mg 120tk; 200mg 500tk; 200mg 30tk; 200mg 90tk; 200mg 20tk; 200mg 100tk
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastilised ained - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
coldrex junior siirup
glaxosmithkline export ltd - paratsetamool+guaifenesiin+fenüülefriin - siirup - 25mg+10mg+0,5mg 1ml 160ml 1tk
levatum super süstelahus
chanelle animal health ltd - ivermektiin+klorsuloon - süstelahus - 10mg+100mg 1ml 50ml 1tk; 10mg+100mg 1ml 500ml 1tk; 10mg+100mg 1ml 250ml 1tk
cefuroxime mip 750 mg süstelahuse pulber
mip pharma gmbh - tsefuroksiim - süstelahuse pulber - 750mg 1tk; 750mg 5tk; 750mg 10tk